Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brucellosis
Data from University of Buenos Aires advance knowledge in Brucellosis
October 1st, 2008
According to recent research from Buenos Aires, Argentina, "The pathological consequences of exposure to the vaccine strain Brucella abortus S19 were evaluated in 30 employees from vaccine-manufacturing plants. Active brucellosis was diagnosed in 21 subjects, of whom only five recalled an accidental exposure." "Clinical manifestations were mild, and only one patient presented a complication. After antimicrobial therapy, initially symptomatic patients either experienced clinical remission or had mild persistent symptoms. This is the study reporting infection by B. abortus S19 am workers from vaccine-manufacturing plants, which in many cases was acquired from unnoticed...
Source: Vaccine Weekly (2008-10-01)
|
